FIELD: organic chemistry, medicine. SUBSTANCE: product: p-chlorophenylsulfonylacetic acid tris-(2-hydroxyethyl)-ammonium salt. Synthesis is carried out from p-chlorophenylsulfonylacetic acid and triethanolamine in ethanol medium at boiling. Yield is 90%, m. p. is 92-93 C, empirical formula is C14H22ClNO7S. Activity of product exceeds that of clofibrate, toxicity LD50 = 6000 ± 108 mg/kg (intaperitoneally), active dose 25 mg/kg decreases cholesterol level in blood by 53.5% as compared with control value. Synthesized compound can be used for prophylaxis and treatment of atherosclerosis. EFFECT: enhanced effectiveness, high yield. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
HYPOCHOLESTEROLEMIC AGENT | 1992 |
|
RU2034540C1 |
IMMUNOSTIMULATING AGENT | 2002 |
|
RU2228175C1 |
HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
MEDICINAL-PROPHYLAXIS AGENT OF CHOLESTEROL-REGULATING ACTION AND A METHOD OF DISEASE TREATMENT CAUSED CHOLESTEROL METABOLISM DAMAGE IN ORGANISM | 1993 |
|
RU2043111C1 |
AGENT FOR TREATMENT OF PATIENTS WITH HYPERLIPIDEMIA AND ATHEROSCLEROSIS | 1999 |
|
RU2164408C2 |
AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
METHOD OF PREPARING OF AGENT SHOWING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC EFFECT | 1991 |
|
RU2011383C1 |
ANTIINFLAMMATORY AGENT | 1992 |
|
RU2086239C1 |
Authors
Dates
1996-06-10—Published
1986-12-22—Filed